BTAI
BioXcel Therapeutics, Inc. Common Stock
$1.63
-1.80%
-0.03
Notify me if price changes either direction
Buy BTAI stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
36.5M
Enterprise value
109.6M
Trailing PE
-0.068906848149724
Forward PE
-0.6007194
PEG Ratio
0.0012000104167571
Enterprise to EBITDA
-2.186
Enterprise to revenue
145.787
Price to book MRQ
-0.25863448756734
Price to sales TTM
48.56656
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
752.0K
EBITDA
-50143000
Diluted EPS TTM
-9.29
Total Cash (MRQ)
36.2M
Current ratio (MRQ)
1.175
Operating Cash Flow (TTM)
-58214000
BTAI trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
